Featured JAX® Mice for Cancer Research
Browse the most popular and newly emerging models for the study of human cancer including induced, transgenic, and conditional mouse models.
The Jackson Laboratory provides the most widely published and cutting-edge models for oncology research and offers a comprehensive suite of solutions for your oncology research needs.
Over 400 patient-derived xenograft (PDX) tumors are available for engrafting into immunocompromised NSG™ mice for shipment to your facility or use in JAX-directed preclinical efficacy studies.
A robust immuno-oncology platform for efficacy testing of novel immunotherapies targeting T cells and myeloid cells.
Jeff Chuang has summarized the power of 3D cell models and mapped out the key milestones required for implementation of...
In a new paper, Jennifer Trowbridge presents the factors and processes that contribute to Hematopoietic stem cells decline...
A stable iPSC line, KOLF2.1J, has been established to act as a high-quality baseline platform for modeling human disease.
JAX is playing a major role to bridge experimental mouse and human data and reveal the biology of senescent cells.
Trowbridge has been recognized as an outstanding early-career scientist and will receive a $750,000 award.
Learn about how cancer is formed in this Minute to Understanding video from The Jackson Laboratory.
Humans have about 20,000 genes (give or take), far fewer genes than many so-called “primitive” animals, like Daphina pulex, a.k.a. the...
Recipients of the 2022 Brooks Scholar Award represent a new generation of scientists whose research bridges the fields of...
Eight team members who make up JAX's MCGI recently attended MaineGeneral's annual Day of Hope Event at the Augusta Civic...
This two-day course will help emerging scientists equip themselves with the professional, interpersonal and communication skills that...
PDX LIVE TUMOR INTEREST FORM - ACADEMIC PRICING
Free online CME for physicians: Practice weighing the benefits, risks, and limitations of different genetic tests within specific patient...